Search Within

Robert Motzer

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (87)
  2. Meeting Abstract (71)
  3. Book Section (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (160)
  2. Epidemiology and Biostatistics (160)
  3. Genitourinary Oncology Service (160)
  4. Solid Tumor Oncology Division (160)
  5. Biostatistics Service (123)
  6. Surgery (103)

More Groups

People
  1. Sujata Patil (93)
  2. Darren Feldman (89)
  3. Martin Voss (85)
  4. Abraham Hakimi (68)
  5. Paul Russo (51)
  6. Chung-Han Lee (45)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (5)
  4. 2022 (9)
  5. 2021 (15)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (73)
  2. Cancer (9)
  3. Clinical Genitourinary Cancer (8)
  4. Clinical Cancer Research (7)
  5. European Urology Focus (5)
  6. European Urology Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (74)
  2. Elsevier Inc. (15)
  3. Wiley Blackwell (13)
  4. American Association for Cancer Research (11)
  5. Elsevier Science, Inc. (7)
  6. Oxford University Press (7)

More Publishers

Results (160)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: Implications for clinical trial design and interpretation
    Journal Article

    Patil, S.; Ishill, N.; Deluca, J.; Motzer, R. J.
    Cancer (2010)

    Fulltext@MSK | Save
  • Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
    Journal Article

    Feldman, D. R.; Turkula, S.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Carousso, M.; Bosl, G. J.; Motzer, R. J.
    Investigational New Drugs (2010)

    Fulltext@MSK | Save
  • Prognostic factors for overall survival with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Patil, S.; Figlin, R. A.; Hutson, T. E.; Michaelson, M. D.; Negrier, S.; Kim, S. T.; Huang, X.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Treatment outcome and survival for patients (pts) with sarcomatoid-variant metastatic renal cell carcinoma (RCC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Molina, A. M.; Tickoo, S. K.; Ishill, N.; Trinos, M. J.; Schwartz, L. H.; Russo, P.; Feldman, D. R.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Kroog, G. S.; Feldman, D. R.; Kondagunta, G. V.; Ginsberg, M. S.; Fischer, P. M.; Trinos, M. J.; Patil, S.; Ishill, N. M.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Paclitaxel (T) plus ifosfamide (I) followed by high-dose carboplatin (C) and etoposide (E) with autologous stem cell support for patients (pts) with previously treated germ cell tumors (GCT): TI-CE results and prognostic factor analysis in 107 pts
    Meeting Abstract

    Feldman, D. R.; Sheinfeld, J.; Bajorin, D. F.; Fischer, P.; Turkula, S.; Ishill, N.; Patil, S.; Bains, M.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Feldman, D. R.; Baum, M. S.; Ginsberg, M. S.; Hassoun, H.; Flombaum, C. D.; Velasco, S.; Fischer, P.; Ronnen, E.; Ishill, N.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Trends in Memorial Sloan-Kettering Cancer Center risk group distribution according to treatment year for patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Patil, S.; Ishill, N. M.; Deluca, J.; Motzer, R. J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Hypoxia-inducible factor (HIF) 1α and 2α levels in cell lines and human tumor predicts response to sunitinib in renal cell carcinoma (RCC)
    Meeting Abstract

    Patel, P. H.; Chadalavada, R. S.; Ishill, N. M.; Patil, S.; Reuter, V. E.; Motzer, R. J.; Chaganti, R. S.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors
    Journal Article

    Jathavedam, A.; Feldman, D. R.; Ishill, N.; Turkula, S.; Patil, S.; Bosl, G. J.; Motzer, R. J.; Weinstock, D. M.
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save